Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6241237 | Respiratory Medicine | 2016 | 6 Pages |
Abstract
These data suggest that LCI may potentially be used as an outcome measure in early phase trials with therapeutic agents that have a larger treatment effects than a single inhalation of HS.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Reshma Amin, Sanja Stanojevic, Mica Kane, Hailey Webster, Felix Ratjen,